Michael Arulfo, CPM, CLP, CSPO, has built a distinguished career at the intersection of enterprise architecture and ...

UnitedHealth Group stands out as a solid investment choice amidst financial uncertainty. With an equity beta of 0.67, it ...

A colonoscopy can help detect colorectal cancer early, greatly improving your prognosis. Sponsored by Optum Care Washington.

RiverPark Advisors, an investment advisory firm and sponsor of the RiverPark family of mutual funds, released its “RiverPark ...

His parents have now filed a lawsuit against both the pharmacy benefits-management company and Walgreens, claiming they are responsible for their son's death. The Schmidtknechts' ...

Vertex's Journavx, a new non-opioid pain drug, lands Tier 3 on Optum Rx formularies. Vertex reports $2.91 billion Q4 sales.

Southwest Medical has added a new physician to help meet the growing need for health services in Southern Nevada: Stephanie Insixiengmai, MD joins Southwest Medical’s Rancho Urgent Care (888 S. Rancho ...

Optum Rx, the pharmacy benefit manager owned by UnitedHealth Group, placed Journavx on some of its commercial formularies in ...

The Boston-based company's new medication, called Journavx, is being placed on a tier that means it might be costlier than ...

Vertex Pharmaceuticals’ (VRTX) non-opioid pain drug Journavx was picked up by UnitedHealth’s (UNH) Optum on “Tier 3.” The insurer said, ...

Vertex Pharma (VRTX) stock slips as UnitedHealth (UNH) offers its pain drug Journavx Tier 3 coverage, setting a rivalry with ...